Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06650540
NA

Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis

Sponsor: Peking University Third Hospital

View on ClinicalTrials.gov

Summary

This is a single randomised controlled trial. The investigators plan to randomise 800 participants to the levofloxacin plus metronidazole suppositories versus levofloxacin co-administered with metronidazole tablets for the treatment of chronic endometritis in a 1:1 rate. Primary outcome will be the live birth rate after the embryo transfer.

Official title: Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets for the Treatment of Chronic Endometritis: a Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

20 Years - 42 Years

Study Type

INTERVENTIONAL

Enrollment

800

Start Date

2024-10-22

Completion Date

2026-12-30

Last Updated

2024-10-21

Healthy Volunteers

No

Conditions

Interventions

DRUG

Levofloxacin Plus Metronidazole Suppositories

Administer a two-week course of Levofloxacin Plus Metronidazole Suppositories to patients diagnosed with chronic endometritis.

BIOLOGICAL

Levofloxacin co-administered with Metronidazole tablets

Administer a two-week course of Levofloxacin in combination with Metronidazole tablets to patients diagnosed with chronic endometritis.

Locations (1)

Peking university third hospital

Beijing, China